Updated evidence on raspberries as functional foods: Anticancer bioactivity and therapeutic implications

Raspberries (RBs) (Rubus idaeus) are rich in bioactive compounds with promising anticancer properties. This review provides a comprehensive analysis of the anticancer effects of RBs, highlighting their potential as natural agents in cancer prevention and therapy. Bioactive compounds in RBs induce apoptosis, arrest the cell cycle, inhibit angiogenesis, and suppress metastasis. Preclinical studies demonstrate significant anticancer effects against colon, breast, lung, prostate, and cervical cancers, with clinical studies also supporting their therapeutic potential. Although preclinical findings are encouraging, further large-scale clinical trials are needed to confirm their efficacy and safety in humans. Optimizing formulations to enhance bioavailability and therapeutic effectiveness is crucial. This review emphasizes the potential of dietary interventions involving RBs as a complementary approach to conventional cancer therapies, paving the way for future research and clinical innovations. Raspberries (Rubus idaeus) contain bioactive compounds with significant anticancer properties, including apoptosis induction, cell cycle arrest, and metastasis suppression. This review consolidates current research on these mechanisms, highlighting the potential of raspberry bioactives as natural anticancer agents and emphasizing the need for further clinical trials to confirm their therapeutic efficacy and safety in humans. image